Literature DB >> 1493918

Polyclonal activation of B lymphocytes by lipopolysaccharide requires macrophage-derived interleukin-1.

R Bucala1.   

Abstract

Lipopolysaccharide (LPS) is a potent murine polyclonal B-cell activator which induces cellular proliferation and IgM secretion. The precise role of activated macrophages in the induction of LPS-dependent, B-cell responses has been unclear. Although early reports concluded that the LPS effect occurs independently of other cell types, other studies have suggested that adherent macrophages exert either potentiating or inhibitory effects. In the present study, B-cell mitogenesis and IgM production were measured in primary spleen cell cultures after removing adherent cells by a variety of experimental procedures. B-cell activation by LPS was found to be strictly dependent on the presence of adherent macrophages. Antibody neutralization and cytokine reconstitution studies demonstrated that macrophage-derived interleukin- (IL-1) is a necessary co-factor for LPS-induced polyclonal activation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1493918      PMCID: PMC1421668     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  37 in total

Review 1.  Thymus-independent B-cell induction and paralysis.

Authors:  A Coutinho; G Möller
Journal:  Adv Immunol       Date:  1975       Impact factor: 3.543

2.  Induction of antigen-specific proliferation in affinity-purified small B lymphocytes: requirement for BSF-1 by type 2 but not type 1 thymus-independent antigens.

Authors:  P Stein; P Dubois; D Greenblatt; M Howard
Journal:  J Immunol       Date:  1986-03-15       Impact factor: 5.422

3.  Selective induction of DNA synthesis in T and B lymphocytes.

Authors:  J Andersson; G Möller; O Sjöberg
Journal:  Cell Immunol       Date:  1972-08       Impact factor: 4.868

4.  The polyclonal lipopolysaccharide response is accessory-cell-dependent.

Authors:  C Fernandez; E Severinson
Journal:  Scand J Immunol       Date:  1983-10       Impact factor: 3.487

5.  Anticachectin/tumor necrosis factor-alpha antibodies attenuate development of cachexia in tumor models.

Authors:  B A Sherry; J Gelin; Y Fong; M Marano; H Wei; A Cerami; S F Lowry; K G Lundholm; L L Moldawer
Journal:  FASEB J       Date:  1989-06       Impact factor: 5.191

6.  Interleukin 1 can act as a B-cell growth and differentiation factor.

Authors:  B L Pike; G J Nossal
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

7.  Interleukin 1 (IL 1)-dependent lymphokine production by human leukemic T cell line HSB.2 subclones.

Authors:  T Kasahara; N Mukaida; K Hatake; K Motoyoshi; T Kawai; K Shiori-Nakano
Journal:  J Immunol       Date:  1985-03       Impact factor: 5.422

8.  Tumor necrosis factor stimulates interleukin-1 and prostaglandin E2 production in resting macrophages.

Authors:  P R Bachwich; S W Chensue; J W Larrick; S L Kunkel
Journal:  Biochem Biophys Res Commun       Date:  1986-04-14       Impact factor: 3.575

9.  IL-1 as adjuvant. Role of T cells in the augmentation of specific antibody production by recombinant human IL-1 alpha.

Authors:  S G Reed; D L Pihl; P J Conlon; K H Grabstein
Journal:  J Immunol       Date:  1989-05-01       Impact factor: 5.422

10.  The essential role of B cell stimulatory factor 2 (BSF-2/IL-6) for the terminal differentiation of B cells.

Authors:  A Muraguchi; T Hirano; B Tang; T Matsuda; Y Horii; K Nakajima; T Kishimoto
Journal:  J Exp Med       Date:  1988-02-01       Impact factor: 14.307

View more
  6 in total

1.  Mitogenic response of murine B lymphocytes to Salmonella typhimurium lipopolysaccharide requires protein kinase C-dependent late tyrosine phosphorylations.

Authors:  A Mey; J P Revillard
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

2.  Activation by mitogens and superantigens of axolotl lymphocytes: functional characterization and ontogenic study.

Authors:  F Salvadori; A Tournefier
Journal:  Immunology       Date:  1996-08       Impact factor: 7.397

3.  IL-4 protein expression and basal activation of Erk in vivo in follicular lymphoma.

Authors:  Katherine R Calvo; Bhavana Dabir; Alexandra Kovach; Christopher Devor; Russell Bandle; Amelia Bond; Joanna H Shih; Elaine S Jaffe
Journal:  Blood       Date:  2008-08-05       Impact factor: 22.113

4.  Staphylococcal LTA antagonizes the B cell-mitogenic potential of LPS.

Authors:  Seok-Seong Kang; Sun Kyung Kim; Jung Eun Baik; Eun Byeol Ko; Ki Bum Ahn; Cheol-Heui Yun; Seung Hyun Han
Journal:  Sci Rep       Date:  2018-01-24       Impact factor: 4.379

5.  Comprehensive toxicity and immunogenicity studies reveal minimal effects in mice following sustained dosing of extracellular vesicles derived from HEK293T cells.

Authors:  Xiaohua Zhu; Mohamed Badawi; Steven Pomeroy; Dhruvitkumar S Sutaria; Zhiliang Xie; Alice Baek; Jinmai Jiang; Ola A Elgamal; Xiaokui Mo; Krista La Perle; Jeffrey Chalmers; Thomas D Schmittgen; Mitch A Phelps
Journal:  J Extracell Vesicles       Date:  2017-06-06

6.  The Impact of Hyperosmolality on Activation and Differentiation of B Lymphoid Cells.

Authors:  Ljiljana Cvetkovic; Stojan Perisic; Jens Titze; Hans-Martin Jäck; Wolfgang Schuh
Journal:  Front Immunol       Date:  2019-04-18       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.